Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohisa Nakada

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Toxicological Sciences|June 13, 2012
Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathwayTomohisa Nakada, Kazuma Kiyotani, Shunsuke Iwano, et al.
Clinical and Translational Science|June 3, 2021
Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized liversKosuke Yoshida, Yuki Doi, Norihiko Iwazaki, et al.
Drug Metabolism and Pharmacokinetics|January 7, 2014
Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinineTomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Toxicological Sciences|June 13, 2012
Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathwayTomohisa Nakada, Kazuma Kiyotani, Shunsuke Iwano, et al.
Clinical and Translational Science|June 3, 2021
Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized liversKosuke Yoshida, Yuki Doi, Norihiko Iwazaki, et al.
Drug Metabolism and Pharmacokinetics|January 7, 2014
Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinineTomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, et al.
Pageof 2